

Tuesday, January 24, 2012
immatics presents positive Phase II results with its therapeutic cancer vaccine IMA910
Download : PR 240112
Tuesday, May 17, 2011
Pollen : "Notre produit permet un traitement à 5 injections"
Download : 24H 170511
Vinci Capital - PSE-C - CH-1015 Lausanne - Tel +41 (0)21 693 92 34 - info@vincicapital.ch
Vinci Capital
PSE Bâtiment C
CH-1015 Lausanne
Tel +41 (0)21 693 92 34